Scribd Logo
Upload

Welcome to Scribd!

  • 205 views

    Balance Sheet and P&L of Cipla

    Uploaded by

    Pratik Ahluwalia
    This document contains balance sheet and profit and loss data for Cipla, an Indian pharmaceutical company, from March 2008 to March 2012. Over this period Cipla's net worth grew from Rs. 3,755 crore to Rs. 7,550 crore as profits were retained. Revenue increased from Rs. 4,203 crore to Rs. 6,977 crore while net profit grew from Rs. 701 crore to Rs. 1,124 crore. Book value per share of the company increased from Rs. 48.20 to Rs. 93.92 over the 5 year period.

    Copyright:

    Attribution Non-Commercial (BY-NC)
    Download as DOCX, PDF, TXT or read online from Scribd

    Balance Sheet and P&L of Cipla

    Uploaded by

    Pratik Ahluwalia
    205 views2 pages
    This document contains balance sheet and profit and loss data for Cipla, an Indian pharmaceutical company, from March 2008 to March 2012. Over this period Cipla's net worth grew from Rs. 3,755 crore to Rs. 7,550 crore as profits were retained. Revenue increased from Rs. 4,203 crore to Rs. 6,977 crore while net profit grew from Rs. 701 crore to Rs. 1,124 crore. Book value per share of the company increased from Rs. 48.20 to Rs. 93.92 over the 5 year period.

    Original Title

    Balance Sheet and p&l of Cipla

    Copyright

    © Attribution Non-Commercial (BY-NC)

    Available Formats

    DOCX, PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    This document contains balance sheet and profit and loss data for Cipla, an Indian pharmaceutical company, from March 2008 to March 2012. Over this period Cipla's net worth grew from Rs. 3,755 crore to Rs. 7,550 crore as profits were retained. Revenue increased from Rs. 4,203 crore to Rs. 6,977 crore while net profit grew from Rs. 701 crore to Rs. 1,124 crore. Book value per share of the company increased from Rs. 48.20 to Rs. 93.92 over the 5 year period.

    Copyright:

    Attribution Non-Commercial (BY-NC)
    Download as DOCX, PDF, TXT or read online from Scribd
    Download as docx, pdf, or txt
    205 views2 pages

    Balance Sheet and P&L of Cipla

    Uploaded by

    Pratik Ahluwalia
    This document contains balance sheet and profit and loss data for Cipla, an Indian pharmaceutical company, from March 2008 to March 2012. Over this period Cipla's net worth grew from Rs. 3,755 crore to Rs. 7,550 crore as profits were retained. Revenue increased from Rs. 4,203 crore to Rs. 6,977 crore while net profit grew from Rs. 701 crore to Rs. 1,124 crore. Book value per share of the company increased from Rs. 48.20 to Rs. 93.92 over the 5 year period.

    Copyright:

    Attribution Non-Commercial (BY-NC)
    Download as DOCX, PDF, TXT or read online from Scribd
    Download as docx, pdf, or txt
    of 2

    Balance Sheet of Cipla

    ------------------- in Rs. Cr. ------------------Mar '12

    Mar '11

    Mar '10

    Mar '09

    Mar '08

    12 mths

    12 mths

    12 mths

    12 mths

    12 mths

    Total Share Capital


    Equity Share Capital
    Share Application Money
    Preference Share Capital
    Reserves
    Revaluation Reserves
    Networth

    160.58
    160.58
    0.00
    0.00
    7,380.73
    8.97
    7,550.28

    160.58
    160.58
    0.00
    0.00
    6,443.40
    8.97
    6,612.95

    160.58
    160.58
    0.00
    0.00
    5,744.54
    8.97
    5,914.09

    155.46
    155.46
    0.00
    0.00
    4,186.32
    8.97
    4,350.75

    155.46
    155.46
    0.00
    0.00
    3,591.39
    8.97
    3,755.82

    Secured Loans
    Unsecured Loans
    Total Debt
    Total Liabilities

    10.00
    2.20
    12.20
    7,562.48
    Mar '12

    2.95
    438.44
    441.39
    7,054.34
    Mar '11

    0.41
    4.66
    5.07
    5,919.16
    Mar '10

    2.79
    937.45
    940.24
    5,290.99
    Mar '09

    16.98
    563.55
    580.53
    4,336.35
    Mar '08

    12 mths

    12 mths

    12 mths

    12 mths

    12 mths

    Gross Block
    Less: Accum. Depreciation
    Net Block

    4,298.18
    1,295.52
    3,002.66

    3,929.00
    1,060.98
    2,868.02

    2,895.44
    884.27
    2,011.17

    2,693.29
    700.80
    1,992.49

    2,201.79
    540.43
    1,661.36

    Capital Work in Progress


    Investments

    420.73
    1,035.15

    253.07
    570.28

    684.24
    265.10

    366.32
    81.32

    233.12
    94.75

    Inventories
    Sundry Debtors
    Cash and Bank Balance
    Total Current Assets
    Loans and Advances
    Fixed Deposits
    Total CA, Loans & Advances
    Deffered Credit
    Current Liabilities
    Provisions
    Total CL & Provisions
    Net Current Assets

    1,824.50
    1,519.31
    53.82
    3,397.63
    1,136.14
    1.48
    4,535.25
    0.00
    1,190.78
    240.53
    1,431.31
    3,103.94

    1,883.16
    1,497.04
    83.56
    3,463.76
    2,558.23
    0.57
    6,022.56
    0.00
    1,150.72
    1,508.87
    2,659.59
    3,362.97

    1,512.58
    1,552.71
    60.32
    3,125.61
    2,357.29
    0.52
    5,483.42
    0.00
    1,177.11
    1,347.66
    2,524.77
    2,958.65

    1,398.32
    1,837.15
    52.84
    3,288.31
    1,131.10
    0.16
    4,419.57
    0.00
    1,177.00
    391.71
    1,568.71
    2,850.86

    1,120.49
    1,393.91
    79.12
    2,593.52
    1,150.30
    0.16
    3,743.98
    0.00
    980.05
    416.81
    1,396.86
    2,347.12

    Miscellaneous Expenses
    Total Assets

    0.00
    7,562.48

    0.00
    7,054.34

    0.00
    5,919.16

    0.00
    5,290.99

    0.00
    4,336.35

    608.80
    93.92

    478.26
    82.25

    423.87
    73.55

    730.75
    55.86

    1,664.58
    48.20

    Sources Of Funds

    Application Of Funds

    Contingent Liabilities
    Book Value (Rs)

    Cipla

    Profit & Loss account

    ------------------- in Rs. Cr. ------------------Mar '12

    Mar '11

    Mar '10

    Mar '09

    Mar '08

    12 mths

    12 mths

    12 mths

    12 mths

    12 mths

    Sales Turnover
    Excise Duty
    Net Sales
    Other Income
    Stock Adjustments
    Total Income
    Expenditure

    7,074.73
    97.23
    6,977.50
    96.50
    -11.24
    7,062.76

    6,368.06
    48.71
    6,319.35
    109.80
    125.74
    6,554.89

    5,657.85
    52.16
    5,605.69
    125.71
    184.09
    5,915.49

    5,295.33
    61.04
    5,234.29
    -139.51
    113.55
    5,208.33

    4,293.95
    90.66
    4,203.29
    134.92
    41.37
    4,379.58

    Raw Materials
    Power & Fuel Cost
    Employee Cost
    Other Manufacturing Expenses
    Selling and Admin Expenses
    Miscellaneous Expenses
    Preoperative Exp Capitalised
    Total Expenses

    2,903.95
    188.18
    644.79
    259.56
    1,217.79
    154.27
    0.00
    5,368.54
    Mar '12

    3,085.90
    164.42
    464.20
    270.08
    999.68
    179.49
    0.00
    5,163.77
    Mar '11

    2,687.54
    92.15
    318.87
    259.67
    867.98
    182.64
    0.00
    4,408.85
    Mar '10

    2,513.11
    91.71
    271.33
    262.65
    887.28
    76.92
    0.00
    4,103.00
    Mar '09

    2,162.48
    96.90
    255.45
    233.90
    547.10
    96.66
    0.00
    3,392.49
    Mar '08

    12 mths

    12 mths

    12 mths

    12 mths

    12 mths

    Operating Profit

    1,597.72

    1,281.32

    1,380.93

    1,244.84

    852.17

    PBDIT
    Interest
    PBDT
    Depreciation
    Other Written Off
    Profit Before Tax
    Extra-ordinary items
    PBT (Post Extra-ord Items)
    Tax
    Reported Net Profit

    1,694.22
    12.13
    1,682.09
    261.08
    0.00
    1,421.01
    0.45
    1,421.46
    297.50
    1,123.96

    1,391.12
    10.87
    1,380.25
    228.86
    0.00
    1,151.39
    0.00
    1,151.39
    191.00
    960.39

    1,506.64
    28.30
    1,478.34
    165.25
    0.00
    1,313.09
    11.90
    1,324.99
    243.50
    1,081.49

    1,105.33
    52.23
    1,053.10
    151.79
    0.00
    901.31
    0.00
    901.31
    124.50
    776.81

    987.09
    18.05
    969.04
    130.68
    0.00
    838.36
    0.00
    838.36
    136.93
    701.43

    Total Value Addition


    Preference Dividend
    Equity Dividend
    Corporate Dividend Tax
    Per share data (annualised)

    2,464.59
    0.00
    160.58
    26.05

    2,077.87
    0.00
    224.81
    36.72

    1,721.31
    0.00
    160.58
    26.67

    1,589.89
    0.00
    155.46
    26.42

    1,230.01
    0.00
    155.46
    26.42

    Shares in issue (lakhs)


    Earning Per Share (Rs)

    8,029.21
    14.00

    8,029.21
    11.96

    8,029.21
    13.47

    7,772.91
    9.99

    7,772.91
    9.02

    100.00
    93.92

    140.00
    82.25

    100.00
    73.55

    100.00
    55.86

    100.00
    48.20

    Income

    Equity Dividend (%)


    Book Value (Rs)

    You might also like